Statistics about Health, Pharma & Medtech in United States
Statistics
- Clearside Biomedical revenue 2019-2023
- Chemocentryx, Inc. net cash 2017-2021
- Chemocentryx, Inc. liabilities 2017-2021
- Atossa Therapeutics total assets 2019-2023
- Neuropathix, Inc. liabilities 2017-2021
- Clearside Biomedical operating profit 2019-2023
- Chemocentryx, Inc. total assets 2017-2021
- Atossa Therapeutics total equity 2019-2023
- Chemocentryx, Inc. operating profit 2017-2021
- Actinium Pharmaceuticals liabilities 2019-2023
- Atossa Therapeutics operating profit 2019-2023
- Atossa Therapeutics net cash 2019-2023
- Atossa Therapeutics liabilities 2019-2023
- Clearside Biomedical net cash 2019-2023
- America Great Health net income 2016-2020
- Clearside Biomedical total equity 2019-2023
- Chemocentryx, Inc. total equity 2017-2021
- Clovis Oncology operating profit 2017-2021
- Clovis Oncology liabilities 2017-2021
- Nanoviricides liabilities 2017-2024
- Atossa Therapeutics gross profit 2011-2015
- Clovis Oncology net cash 2017-2021
- Clovis Oncology net income 2017-2021
- Actinium Pharmaceuticals net cash 2019-2023
- Adicet Bio operating profit 2019-2023
- Nektar Therapeutics operating profit 2019-2023
- Avenue Therapeutics total equity 2019-2023
- Nanoviricides net income 2020-2024
- Adaptive Biotechnologies total assets 2019-2023
- Nanomix Corp revenue 2018-2022
- Nektar Therapeutics revenue 2019-2023
- Cardio Diagnostics Holdings, Inc. total assets 2021-2023
- Cardio Diagnostics Holdings, Inc. operating profit 2021-2023
- Cardio Diagnostics Holdings, Inc. net cash 2021-2023
- Adaptive Biotechnologies total equity 2019-2023
- Cardio Diagnostics Holdings, Inc. liabilities 2021-2023
- Cardio Diagnostics Holdings, Inc. total equity 2020-2023
- Tourmaline Bio, Inc. operating profit 2020-2023
- Adaptive Biotechnologies net cash 2019-2023
- Cardio Diagnostics Holdings, Inc. net income 2021-2023
- Cardio Diagnostics Holdings, Inc. revenue 2021-2023
- Neuropathix, Inc. net income 2016-2018
- Nanomix Corp net income 2018-2022
- Nkgen Biotech, Inc. net income 2021-2022
- Nektar Therapeutics net income 2019-2023
- Aditxt gross profit 2021-2023
- Nkgen Biotech, Inc. net cash 2021-2023
- Nkgen Biotech, Inc. liabilities 2021-2023
- Cellectar Biosciences, Inc. liabilities 2019-2023
- Nkgen Biotech, Inc. operating profit 2021-2023
- Aditxt operating profit 2019-2023
- Cellectar Biosciences, Inc. operating profit 2019-2023
- Cellectar Biosciences, Inc. net cash 2019-2023
- Aditxt revenue 2021-2023
- Aditxt net income 2019-2023
- Cellectar Biosciences, Inc. total assets 2019-2023
- Nkgen Biotech, Inc. total assets 2021-2023
- Aditxt liabilities 2019-2023
- Neuropathix, Inc. revenue 2017-2021
- Adaptive Biotechnologies net income 2019-2023
- Adicet Bio total assets 2019-2023
- Neuropathix, Inc. gross profit 2015-2017
- Adicet Bio total equity 2019-2023
- Tscan Therapeutics net income 2020-2023
- Tarsus Pharmaceuticals revenue 2020-2023
- Cocrystal Pharma, Inc. revenue 2011-2020
- Tscan Therapeutics revenue 2020-2023
- Cocrystal Pharma, Inc. operating profit 2019-2023
- Cocrystal Pharma, Inc. liabilities 2019-2023
- Cocrystal Pharma, Inc. gross profit 2010-2012
- Cocrystal Pharma, Inc. total equity 2019-2023
- Cocrystal Pharma, Inc. net cash 2019-2023
- Cocrystal Pharma, Inc. total assets 2019-2023
- Adaptive Biotechnologies liabilities 2019-2023
- Theriva Biologics, Inc. operating profit 2019-2023
- Adaptive Biotechnologies revenue 2019-2023
- Cannaisseur Group Inc. operating profit 2022-2023
- Carisma Therapeutics Inc. net income 2022-2023
- Cannaisseur Group Inc. net cash 2022-2023
- Cannaisseur Group Inc. total assets 2022-2023
- Adaptive Biotechnologies operating profit 2019-2023
- Cannaisseur Group Inc. liabilities 2022-2023
- Cannaisseur Group Inc. gross profit 2022-2023
- Nanomix Corp gross profit 2012-2016
- Cannaisseur Group Inc. revenue 2022-2023
- Carisma Therapeutics Inc. operating profit 2019-2023
- Carisma Therapeutics Inc. liabilities 2019-2023
- Carisma Therapeutics Inc. total assets 2019-2023
- Carisma Therapeutics Inc. revenue 2019-2023
- Carisma Therapeutics Inc. net cash 2019-2023
- Carisma Therapeutics Inc. total equity 2019-2023
- Cannaisseur Group Inc. net income 2022-2023
- Avenue Therapeutics net cash 2019-2023
- Terns Pharmaceuticals net income 2020-2023
- Assembly Biosciences, Inc. net cash 2019-2023
- Aytu Bioscience gross profit 2020-2024
- Cell Source total assets 2019-2023
- Neutra Corp. net cash 2018-2022
- Cell Source total equity 2019-2023
- Nexien Biopharma, Inc. net cash 2019-2023